Akurit 4 contains rifampin, isoniazid, pyrazinamide and ethambutol as the main ingredients. The drug is manufactured by Lupine Ltd and prescribed by a doctor, indicated for the treatment of tuberculosis caused by Mycobacterium tuberculosis in adults and children weighing more than 20 kg in the attack phase.

Latent TB carriers are people who carry TB bacteria in an inactive state, do not show signs of illness, have no symptoms, and do not transmit the bacteria to others. People with latent TB infection are at high risk of developing TB disease if their immune system is weakened.

Prevention and treatment of latent tuberculosis is an early preventive measure for healthy people who carry tuberculosis bacteria in their bodies, with the aim of reducing the risk of developing tuberculosis later.

Diagnosis of latent tuberculosis is a measure to help detect early those at risk of tuberculosis, especially those who have had contact with people with pulmonary tuberculosis, to have effective prevention and intervention measures.